Literature DB >> 22965690

Hyponatraemia: Lixivaptan for euvolaemic hyponatraemia.

Susan J Allison.   

Abstract

Entities:  

Year:  2012        PMID: 22965690     DOI: 10.1038/nrneph.2012.204

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  2 in total

1.  Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia.

Authors:  William T Abraham; Johannes Hensen; Peter A Gross; Daniel G Bichet; Richard C Josiassen; DeoDatta S Chafekar; Cesare Orlandi
Journal:  Kidney Int       Date:  2012-08-29       Impact factor: 10.612

2.  Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia.

Authors:  William T Abraham; Guy Decaux; Richard C Josiassen; Yoram Yagil; Nelson Kopyt; Hemant P Thacker; Massimo Mannelli; Daniel G Bichet; Cesare Orlandi
Journal:  Kidney Int       Date:  2012-08-29       Impact factor: 10.612

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.